794 search results for “war on drug” in the Staff website
-
War in the Middle East: What are the implications?
The US-Israeli strikes on Iran have been welcomed by critics of the regime but have also prompted intense concern. They’ve triggered a dangerous domino effect across the region and beyond. Leiden experts share their insights on the potential consequences.
-
From lab discovery to a new drug: the Venture Challenge makes it possible
A breakthrough from the PhD research of medical chemist Elmer Maurits may help patients with autoimmune diseases and blood cancer in the future. But bringing a discovery from the lab to the clinic is not so easily done. Thanks to NWO's Venture Challenge, Maurits and his team will receive ten weeks of…
-
Meiling GaoFaculty of Science
m.gao@biology.leidenuniv.nl | 071 5276592
-
Eline DekeysterFaculty of Social and Behavioural Sciences
e.a.g.dekeyster@fsw.leidenuniv.nl | 071 5272727
-
Skin researcher calls for multidisciplinary collaboration: ‘I want to pool expertise’
In dermatology, there should be a high level of multidisciplinary collaboration among institutes and specialists, Professor of Translational Dermatology, Robert Rissmann, will say in his inaugural lecture on 8 July. He is building an infrastructure that will put pre-clinical and clinical skin research…
-
European Proof of Concept grants for two Leiden researchers
Two Leiden researchers have been awarded ERC Proof of Concept grants. These grants, each worth EUR 150,000, will help the grantees in their efforts to bridge the gap from basic science to real-life applications
-
Special Rapporteur visits Leiden: ‘Suspend the supply of arms to the warring parties’
Francesca Albanese, UN Special Rapporteur for human rights in the occupied Palestinian territories, visited Leiden Law School on 8 December within the scope of International Human Rights Day.
-
A future with tailored therapy for patients with atherosclerosis
The AtheroNeth consortium received €6 million from the Dutch Heart Foundation to gain a better understanding of the differences in disease progression among patients with atherosclerosis. The ultimate goal is to enable personalised treatment.
-
Madeline KavanaghFaculty of Science
m.e.kavanagh@lic.leidenuniv.nl | 071 5272727
-
for effective application of a new revolutionary cholesterol lowering drug resides in a 30 year old Leiden Patent
‘’ And then the world changed forever ,welcome to the future’’. These are the words that Kausik Ray (President of the European Atherosclerosis Society) spoke when the worldwide first dose of inclisiran, a novel SiRNA based cholesterol lowering agent, was administered at the Cardiology lipid clinic at…
-
How Leiden University is taking action against cancer
One in two people will be diagnosed with cancer. World Cancer Day on 4 February raises awareness of the impact of this devastating disease. Leiden University is conducting various studies aimed at preventing and controlling cancer. Below are just a few examples.
-
Can birds imitate Star Wars robot? Yes – and some are surprisingly good at it
Scientists have discovered that starlings and parrots can imitate the complex sounds of Star Wars droid R2-D2 remarkably well. Their study reveals how the structure of a bird’s vocal organ determines its vocal abilities – and how citizen science helps uncover it.
-
Catherine WoodFaculty of Humanities
c.m.wood@hum.leidenuniv.nl | 071 5277177
-
Alies JansenFaculty of Humanities
e.jansen@hum.leidenuniv.nl | 071 5271646
-
Bart van der BoomFaculty of Humanities
b.e.van.der.boom@hum.leidenuniv.nl | 071 5272762
-
Marije NiemeijerFaculty of Science
m.c.niemeijer@lacdr.leidenuniv.nl | 071 5276105
-
Bas ter BraakFaculty of Science
s.j.ter.braak@lacdr.leidenuniv.nl | 071 5272727
-
A faster way to find new medicines – without the limitations of big DNA barcodes
Leiden researchers, led by Sebastian Pomplun developed a new method to screen hundreds of thousands of molecules for drug discovery, using mass spectrometry instead of DNA tags. ‘We wanted to make drug discovery faster and more accessible.’
-
Mario van der SteltFaculty of Science
m.van.der.stelt@chem.leidenuniv.nl | 071 5274768
-
Margo DonaFaculty of Science
m.a.dona@biology.leidenuniv.nl | 071 5272727
-
Corinna Jentzsch
Faculty of Social and Behavioural Sciences
c.jentzsch@fsw.leidenuniv.nl | 071 5273456
-
Personalised medicine? Then you’ll need to look beyond genetics
Why does a medicine work well for one person, but cause side effects in another? Research by Laura de Jong shows that it’s not just our DNA that matters – other medicines and illnesses can also affect how our bodies respond.
-
From discovery to business: 'In the lab, we often don't realise that we are working to help an immense number of patients'
'It gave our team a big boost to hear that our work was valuable,' says medical chemist Elmer Maurits about the moment they won the Venture Challenge. With their company Iprotics, they want to develop a drug that can better treat patients with autoimmune diseases and blood cancers. 25,000 euros of prize…
-
Laura de JongFaculty of Science
l.m.de.jong@lacdr.leidenuniv.nl | 071 5272727
-
RARE-NL: LUMC joins consortium to find treatments for rare diseases
RARE-NL, a new collaboration between university hospitals, hopes to find treatments for rare diseases. Professor Teun van Gelder is representing the LUMC in the initiative.
-
Research and current affairs: 2022 in six stories
Life returned to something resembling normal after Covid but other crises soon took its place. These great challenges are also being felt at the University and our researchers are working on solutions. The nitrogen crisis, problems with young people’s services and an increasingly urgent climate crisis:…
-
Carolien StolteFaculty of Humanities
c.m.stolte@hum.leidenuniv.nl | 071 5277308
-
Erik DanenFaculty of Science
e.danen@lacdr.leidenuniv.nl | 071 5274486
-
Juan Masullo JimenezFaculty of Social and Behavioural Sciences
j.masullo@fsw.leidenuniv.nl | 071 5272727
-
Roxanne KieltykaFaculty of Science
r.e.kieltyka@chem.leidenuniv.nl | 071 5274441
-
The molecular secrets of medicinal cannabis
Chronic pain, nausea or vomiting due to chemotherapy. If you suffer from such ailments, medicinal cannabis can be a godsend. Though a downside is that it can make patients high. Therefore, Leiden researchers from the Oncode Institute are investigating alternatives that do not make you high. In Nature…
-
Sebastian PomplunFaculty of Science
s.j.pomplun@lacdr.leidenuniv.nl | 071 5274651
-
Coen van HasseltFaculty of Science
coen.vanhasselt@lacdr.leidenuniv.nl | 071 5273266
-
Anthe JanssenFaculty of Science
a.p.a.janssen@lic.leidenuniv.nl | 071 5272727
-
Serkan AslanFaculty of Science
s.aslan@lacdr.leidenuniv.nl | 071 5275919
-
ICT-contact persons
For each university unit, the ICT Shared Service Centre (ISSC) has an appointed ICT contact person responsible for applying for ICT facilities for research, teaching and operational management.
-
Malte RiemannFaculty of Governance and Global Affairs
m.riemann@fgga.leidenuniv.nl | 070 8008206
-
Major study offers practical guidance on antibiotic dosing in patients with obesity
Leiden researcher Anne-Grete Märtson brought together a large number of studies to better understand antibiotic dosing in patients with obesity. The publication in a renowned medical journal has already garnered much positive reactions, Märtson says. ‘It’s high time researchers started sharing more…
-
Over a million euros for two studies on solutions to antimicrobial resistance
Two consortia led by Leiden researchers have been awarded over one million euros by the Dutch Research Council and the Ministry of Health, Welfare and Sport to find solutions to antimicrobial resistance.
-
Marie RobinFaculty of Governance and Global Affairs
m.p.c.e.robin@fgga.leidenuniv.nl | 070 8009500
-
Leiden scientists join national effort to advance nanomedicine
A Dutch consortium has received €6.7 million to accelerate the development of nanomedicines together with patients. Researchers from Leiden University play a key role in the project.
-
Annelies Schulte NordholtFaculty of Humanities
a.e.schulte@hum.leidenuniv.nl | 071 5272170
-
How Oncode-PACT is bringing new cancer medicines closer with 325 million in Growth Fund money
How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes it to the market. This is an enormous loss for patients and society. With a grant from the National Growth Fund, Oncode-PACT aims to efficiently select…
-
Study associations sign covenant: limit your alcohol consumption and look after each other
Opting more often for mocktails or soft drinks rather than beer or wine, talking to others about their drinking and pointing out the ban on drugs. Leiden University’s new covenant on alcohol and drugs for study associations encourages providing more alcohol-free alternatives.
-
Thomas HankemeierFaculty of Science
hankemeier@lacdr.leidenuniv.nl | 071 5274226
-
Robotic reconstitution of cytostatic drugs and monoclonal antibodies: transforming aseptic drug compounding in hospital pharmacies
PhD defence
-
Leiden ‘super antibiotic’ keeps dangerous gut bacterium under control with a low dose
The antibiotic EVG7, developed in Leiden, has proven capable of fighting the dangerous gut bacterium C. difficile with only a minimal dose. What’s more, the bacterium is far less likely to return, a major issue with existing antibiotics. The research was published in Nature Communications.
-
‘Never stop trying’: Barz sees his polymers enter clinical trials
A new class of polymers has been used in patients for the first time. The compound is the first new drug solubilising agent in decades. Introduced in 2014 by chemist Matthias Barz from Leiden University, it offers a unique alternative to current options.
-
Vici grants for research into antibodies, galaxies and Indigenous communities
Three Leiden researchers have been awarded a Vici grant by the Dutch Research Council. The funding of up to 1.5 million euros supports ‘talented, adventurous and pioneering researchers’. A total of 39 projects at Dutch institutions will receive a grant.
-
Jonah Schulhofer-WohlFaculty of Social and Behavioural Sciences
j.b.schulhofer-wohl@fsw.leidenuniv.nl | 070 8003903